Dr. Smith-Whitley is the Medical Director of the Sickle Cell Clinical Program, the Clinical Director of the Division of Hematology, an Associate Professor of Pediatrics and she holds the Elias Schwartz, MD, Endowed Chair in Hematology.
Her clinical and research focus is on sickle cell survivorship: predicting and preventing long-term, chronic, and life-threatening complications of the disease. She initiated two innovative programs at CHOP:
- A short-stay Hematology Acute Care Unit
- The Blue Tie Tag program to recruit blood donors for pediatric transfusions
She received the 2010 Blockley-Osler Award for excellence in teaching clinical medicine at the bedside.
- Education and Training
George Washington University School of Medicine, Washington, DC
Children's National Medical Center, Washington, DC
The Children's Hospital of Philadelphia, Philadelphia, Pa.
American Board of PediatricsAmerican Board of Pediatrics/Hematology-Oncology
- Titles and Academic Titles
Medical Director, Sickle Cell Clinical Program
Clinical Director, Division of Hematology
- Conditions Treated
- Departments and Services
Bride KL, Vincent T, Smith-Whitley K, Lambert MP, Bleesing JJ, Seif AE, Manno CS, Casper J, Grupp SA, Teachey DT. Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial. Blood. 2016 Jan 7;127(1):17-28.